“amgen” Archives

in
Entry Author Date Location
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool 09/19/17 Wisconsin
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Novartis: CAR-T Results In One Month, Or No Charge. Why One Month? 08/31/17 National
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
70% Repatha Cut? Amgen Counters With Own Study To Justify Price 08/23/17 National
GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech 08/23/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Radius Health Ramps Up for Market as FDA Rejects Rival Amgen Drug 07/17/17 Boston
Alder Drug Cuts Down Migraines in Study, But Still Trails Rivals 06/27/17 Seattle
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group 06/13/17 San Francisco
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Radius Shares Jump as Amgen’s Bone Drug Suffers a Setback in Phase 3 05/22/17 San Francisco
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug 04/26/17 New York
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Page 1 of 18 next page »